喀什可以取环的地方(喀什包皮过长割一次大概多少钱) (今日更新中)

WASHINGTON, Sept. 14 (Xinhua) -- Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published Wednesday in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.Led by Yale Professor Hugh Taylor, the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three- week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.Taylor said in a statement that the next step in the research will be to verify how long this treatment remains effective.

CANBERRA, Sept. 9 (Xinhua) -- Australia on Friday launched the first national study to find out whether low to moderate levels of alcohol drank by pregnant women are harmful or not to an unborn child, hoping to provide a clear indication about the safe amount of alcohol for pregnant women.The Murdoch Children's Research Institute in Melbourne, which commissioned the study, is recruiting 2000 pregnant women who will be quizzed throughout their pregnancy about their drinking habits, general health and diets.Their babies will then undergo medical checks, when they turn one and again at two to see if their brains, development and behavior was affected by alcohol consumed by their mums.According to lead researcher associate professor, Jane Halliday, while there was solid evidence about the dangers of heavy drinking for an unborn baby, it was not known if there was a safe amount of alcohol pregnant women could drink.She said the study hoped to shed light on the best approach to alcohol use during pregnancy."The problem is that for about half of women that get pregnant it is unplanned, and a lot of women are drinking around the time they get pregnant and may drink for the first month or so and that creates a lot of anxiety," Assoc Prof Halliday said in a statement."From the few international and Australian studies there's conflicting evidence as to whether there's an adverse effect."We firmly believe that no drinking is the safest option, but our main aim is to provide an evidence base to the policy and answer questions about individual risks."The study came after research by the University of Newcastle published in 2010 revealed 80 percent of Australian women drank during pregnancy.

LOS ANGELES, June 29 (Xinhua) -- The war on cloud intensified as Microsoft Office announced its decision on Tuesday to go cloud in an attempt to compete with its immediate but not last competitor, Google Docs.Microsoft holds a virtual monopoly on office productivity software. Most computer users in the world use the Office software for word processing, spreadsheet, presentation and other purposes. However, Microsoft Office faces a strong enemy -- Google Docs, which provides cloud service, that means users do not have to purchase any software to be installed on their computers. If they go online, they can start use the application, and they do not need to worry about their files, because the files also go with the cloud, and users can get access to their files at anytime, anywhere.The cloud-based Office 365 is designed for the mobile age when people go with their software and documents.The actual features and functionality of the tools have a lot of bearing on which productivity suite users choose. The Word Web App is more visually appealing and polished than its Google counterpart, but overall the two seem roughly equivalent in features.When tested on a sample presentation in both the PowerPoint Web App and Google Docs Presentation, the PowerPoint Web App immediately presented with a diverse selection of attractive themes to choose from, but Google defaulted to plain black text on a plain white background.On slide and image, in Google Presentations, the image filled the whole slide but the PowerPoint Web App was smart enough to size the image automatically.When push comes to shove, the features of the Office Web Apps in Office 365 are pretty much the same as what Google Docs has to offer. However, Microsoft makes key features easier to get to, and works more intuitively. For users already familiar with Microsoft Office, the Office Web Apps version is easy to use.Both Office 365 and Google Docs are Web-based platforms, and they will work from any Web browser. Google Docs excels in the Chrome browser while Microsoft Office 365 works best in Internet Explorer. It makes sense that each would make sure that their online productivity tools are optimized for performance and functionality in their own browser.Collaboration in real time is the primary selling point of Google Docs, which can be shared with any other Google account. The users who share a file can all access and work with it simultaneously. Each user is assigned a unique color so users can easily identify who is making changes to what.But in the price war, Microsoft can not beat Google Docs. Office 365 starts at six dollars per user per month for the Professional and Small Business plan. The Medium Business and Enterprise plans range from 10 to 27 dollars per user per month. But the Google Docs is free.Microsoft also faces a challenge on how to go cloud while still keep the computer-based Office software.Statistics showed that nearly nine of every 10 office computers runs one of the 14 versions of Office the company has released since the software's launch in 1989. The company now needs to convince those computer users, estimated at about one billion, to switch to Office in the cloud without disrupting the legacy version that is financing the transition.The growing cloud market is profitable. The International Data Corp. projected the market for cloud-computing services and software is expected to grow more than 27 percent annually over the next five years and reach 73 billion dollars by 2015.It is estimated that by 2015 one of every seven dollars spent on technology will be connected with cloud computing and the winners of the cloud platform wars will likely be the new power brokers of the IT industry.It is reported that Salesforce.com has added a communication technology called Chatter to its service to allow clients to communicate within its sales management cloud service. Amazon's Elastic Cloud has attracted enterprise customers because of its ability to scale up capacity to match peaks in client demand.By 2015, it is estimated that software-oriented cloud services will account for roughly three-quarters of all spending on public cloud services. Enditem

CANBERRA, June 10 (Xinhua) -- Going to work when you are feeling sick can make you sicker in the long run, an expert told Australia's media on Friday.New Zealand sociologist Professor Kevin Dew from the Victoria University in Wellington, has assessed more than 40 papers about " presenteeism".He defined presenteeism as: "People that are turning up at work when they feel that they should be at home sick.""People feel compelled to go to work because someone else would have to take up the workload (and they have a) feeling of responsibility for not being able to care properly for patients (if they don't show up)," he told the Australia Associated Press on Friday.He said that evidence suggested people who go to work when they are sick can have long term negative effects on health and productivity.Evidence shows that presenteeism increases illness, including musculoskeletal pain, fatigue, depression, and serious coronary events. It also leads to exhaustion which, in turn, leads to more presenteeism.Prof. Dew said certain medical conditions like depression and migraine are also linked with presenteeism because they are not seen as legitimate reasons for absence.He has written an editorial in the latest issue of the British Medical Journal about his findings.

BEIJING, Aug. 18 (Xinhua) -- A controlled trial has found that Chinese herbal medicine decoction maxingshigan-yinqiaosan has a similar efficacy to oseltamivir in reducing time to fever resolution in people suffering mild H1N1 influenza virus infections.Carried out by a group of Chinese researchers, headed by Prof. Wang Chen with Beijing Chao-Yang Hospital under the Capital Medical University, the study was published by the famous internal medicine journal Ann Intern Med on Tuesday.Participants of the trial were 410 young adults aged 15 to 59 years with laboratory-confirmed H1N1 influenza.The researchers concluded that both active intervention, alone and in combination, were effective in reducing time to fever resolution in young adults with H1N1 flu, and therefore suggest that maxingshigan-yinqiaosan may be an alternative to oseltamivir.

来源：资阳报